REGENXBIO
Developing gene therapy products
- B2B
About REGENXBIO
A biotechnology innovator specializing in developing and licensing gene therapy products using a proprietary AAV gene delivery platform
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- rockville, maryland, United States
- Founded
- 2008
- Revenue
- $170MFY2025, publicly reported
- Website
- regenxbio.com
- linkedin.com/company/regenx
REGENXBIO at a glance
REGENXBIO is a B2B company in the Biotechnology Research industry, headquartered in rockville, maryland, United States.
REGENXBIO was founded in 2008.
REGENXBIO has 251–1,000 employees.
REGENXBIO's revenue is $170M (FY2025, publicly reported).
Selling to companies like REGENXBIO?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies